Package 50268-826-01

{"route": ["ORAL"], "spl_id": "42501349-0107-5655-e063-6394a90a9b0c", "openfda": {"nui": ["N0000182142", "N0000008832", "N0000182143", "N0000182141", "N0000185503"], "unii": ["GLH0314RVC"], "rxcui": ["1116635"], "spl_set_id": ["425024ab-e092-7a6d-e063-6294a90ae4f3"], "pharm_class_pe": ["Decreased Platelet Aggregation [PE]"], "pharm_class_epc": ["P2Y12 Platelet Inhibitor [EPC]"], "pharm_class_moa": ["P2Y12 Receptor Antagonists [MoA]", "Cytochrome P450 3A4 Inhibitors [MoA]", "P-Glycoprotein Inhibitors [MoA]"], "manufacturer_name": ["AvPAK"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "100 BLISTER PACK in 1 BOX (50268-826-01)  / 1 TABLET in 1 BLISTER PACK (50268-826-11)", "package_ndc": "50268-826-01", "marketing_start_date": "20251029"}], "brand_name": "TICAGRELOR", "product_id": "50268-826_42501349-0107-5655-e063-6394a90a9b0c", "dosage_form": "TABLET", "pharm_class": ["Cytochrome P450 3A4 Inhibitors [MoA]", "Decreased Platelet Aggregation [PE]", "P-Glycoprotein Inhibitors [MoA]", "P2Y12 Platelet Inhibitor [EPC]", "P2Y12 Receptor Antagonists [MoA]"], "product_ndc": "50268-826", "generic_name": "TICAGRELOR", "labeler_name": "AvPAK", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "TICAGRELOR", "active_ingredients": [{"name": "TICAGRELOR", "strength": "90 mg/1"}], "application_number": "ANDA208596", "marketing_category": "ANDA", "marketing_start_date": "20251029", "listing_expiration_date": "20261231"}